Answers are grounded in this paper and cite their sources.
Inflammation score may be associated with for OS in high-risk, adrenergic tumors. A, OS was significantly better for TCI tumors than NI tumors in ADRN patients in the Discovery cohort and B, trended similarly in the Validation cohort. C, There was no difference in survival for patients with MES tumors according to TCI status in the Discovery cohort. D, the MES patients in the Validation also had no difference in OS according to the TCI status.
No takes yet. Share an insight, caveat, or question.
Kaufman et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: